The combination of company driven catalysts over the next 17 months and potential non company catalysts such as significant changes to analysts coverage/price targets and Institutional ownership makes it impossible to predict. As always, I fall back on a personal risk/reward calculation. I'm betting heavy on Upside vs. Downside within that 17 month timeframe.